Last reviewed · How we verify
A Phase IV,Open Label Study of the Treatment of Children With Moderate to Severe Atopic Dermatitis (AD) Using Locobase® REPAIR as an Adjunctive to Standard Treatment
To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD
Details
| Lead sponsor | Astellas Pharma Europe B.V. |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 49 |
| Start date | 2008-03 |
| Completion | 2008-09 |
Conditions
- Dermatitis, Atopic
Interventions
- Locobase® REPAIR
Primary outcomes
- Change in mEASI from baseline to week 3 — 3 Weeks
Countries
United Kingdom